Clinical Scorecard: Systematic Review of Evidence-Based Strategies for Enhancing Female Fertility in Women Aged 30 to 42 Years by Etiology and Evidence Quality

At a Glance

Key Highlights

• Infertility affects approximately one in six couples globally.
• Common etiologies include ovulatory disorders, endometriosis, and low ovarian reserve.
• Interventions like myo-inositol and clomiphene with sildenafil show improved pregnancy outcomes.
• Live birth effects are supported by moderate-certainty evidence.
• Safety reporting in studies is limited.

Guideline-Based Recommendations

Diagnosis

• Utilize serum progesterone profiling and endometrial receptivity assays.

Management

• Prioritize established hormonal therapies and ART strategies.

Monitoring & Follow-up

• Assess maternal-neonatal safety and patient-reported outcomes.

Risks

• Monitor for ovarian hyperstimulation syndrome and multiple gestation.

Patient & Prescribing Data

Women aged 30-42 years experiencing infertility.

Evidence suggests a need for personalized treatment approaches based on etiology.

Clinical Best Practices

• Adopt standardized core outcomes for fertility interventions.
• Encourage shared decision-making with patients regarding treatment options.
• Focus on early identification of modifiable risk factors.

Related Resources & Content

• Systematic Review Registration